Orthopedic device developer Trilliant Surgical has raised $5 million in a new round of equity financing, according to a recently posted SEC filing.
Money in the round came from a single anonymous investor, with the date of the first sale noted on February 27, according to the filing.
The Houston, Texas-based company, founded in 2007, is developing devices for small bone orthopedic corrections including bone and joint elective and trauma procedures for the foot and ankle.
Trilliant is currently offering ten products for the forefoot, mid foot, rear foot and ankle, according to its website.
The company has not yet stated how it plans to spend funds in the round.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.